vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$25.65
—
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
Implied Upside
+63.7%
Consensus $42.00 vs current $25.65
NASDAQ·Healthcare·Biotechnology
$25.65
—
Mkt Cap $95.58M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
+63.7%
Consensus $42.00 vs current $25.65